Sculptra
Description
Sculptra® is an injectable cosmetic treatment containing poly-L-lactic acid (PLLA). It is used for selected aesthetic indications to support a gradual improvement in the appearance of facial volume loss and contour. Before treatment, an individualized assessment is completed to determine whether Sculptra® is appropriate for the client. The assessment considers the client's health history, medications, allergies or sensitivities, previous aesthetic treatments, treatment goals, relevant contraindications, skin and tissue characteristics, and the proposed treatment area. The treatment plan, product selection, treatment areas, and approach are individualized according to the client's assessment, the product's Canadian-approved information and manufacturer's directions for use, the practitioner's education and competence, applicable authorization, and professional requirements. Results develop gradually and vary between individuals. Multiple treatment sessions may be recommended depending on the client's treatment goals and clinical assessment. Results are not guaranteed. Temporary swelling, redness, tenderness, bruising, discomfort, or other local reactions may occur following treatment. Other complications are possible, including inflammatory reactions, nodules or lumps, infection, asymmetry, and other adverse tissue reactions. Rare but serious complications can occur with injectable cosmetic procedures and may require prompt medical assessment and treatment. Before treatment, the practitioner will discuss the anticipated benefits, limitations, material risks, alternatives, expected recovery, and circumstances requiring prompt or urgent medical assessment. Treatment will proceed only after appropriate assessment, authorization, and informed consent. Sculptra® is administered using appropriate infection-prevention and control practices and in accordance with applicable regulatory requirements, product information, manufacturer instructions, and the practitioner's professional competence.
